[Non-compliance and lack of indications for depot treatment as reasons for exclusion from adequate prevention of recurrence].

Jakobitsch, A; Haug, H J; Greger, J; Osterheide, M; Pach, J; Sprenger, R; Tegeler, J; Budde, G

[Non-compliance and lack of indications for depot treatment as reasons for exclusion from adequate prevention of recurrence]. / Non-Compliance und fehlende Indikation zur Depotbehandlung als Ausschlussgründe für eine adäquate Rezidivprophylaxe.

Jakobitsch, A; Haug, H J; Greger, J; Osterheide, M; Pach, J; Sprenger, R; Tegeler, J; Budde, G.

Affiliation

Jakobitsch A; Psychiatrische Universitätsklinik Basel.

Psychiatr Prax ; 23(5): 236-9, 1996 Sep.

Article in De | MEDLINE | ID: mdl-8992517

Subject(s)

Flupenthixol/analogs & derivatives; Schizophrenia/rehabilitation; Schizophrenic Psychology; Tranquilizing Agents/administration & dosage; Treatment Refusal/psychology; Double-Blind Method; Flupenthixol/administration & dosage; Flupenthixol/adverse effects; Humans; Patient Selection; Psychiatric Status Rating Scales; Recurrence; Tranquilizing Agents/adverse effects; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Schizophrenic Psychology / Tranquilizing Agents / Treatment Refusal / Flupenthixol Type of study: Clinical_trials Limits: Humans Language: De Journal: Psychiatr Prax Year: 1996 Document type: Article Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links